Pure Global

BioMérieux Trial Gradient Strip Antibiotic Susceptibility Test - Bibecillin/Da Suxostatin - Taiwan Registration 5b60caaa4d98f41ec03cf68a0b5afba8

Access comprehensive regulatory information for BioMérieux Trial Gradient Strip Antibiotic Susceptibility Test - Bibecillin/Da Suxostatin in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5b60caaa4d98f41ec03cf68a0b5afba8 and manufactured by bioMérieux SA. The authorized representative in Taiwan is Hong Kong Commercial Mérieux S.p.A. Taiwan Branch.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
5b60caaa4d98f41ec03cf68a0b5afba8
Registration Details
Taiwan FDA Registration: 5b60caaa4d98f41ec03cf68a0b5afba8
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BioMérieux Trial Gradient Strip Antibiotic Susceptibility Test - Bibecillin/Da Suxostatin
TW: 生物梅里埃易特試梯度條抗生素感受性檢測 - 必倍西林/達梭抑黴素
Risk Class 2

Registration Details

5b60caaa4d98f41ec03cf68a0b5afba8

DHA05603246703

Company Information

France

Product Details

This product is a manual quantitative detection technique for antibiotic susceptibility, which can be used to determine the minimum inhibitory concentration of Piperacillin/Tazobactam in μg/mL for Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp.

C Immunology and microbiology

C.1640 抗菌感受性試驗粉末

QMS/QSD;; 輸入

Dates and Status

Jul 22, 2019

Jul 22, 2024

Oct 15, 2024